Stockreport

Why Protagonist Therapeutics (PTGX) Is Up 11.3% After Rusfertide NDA And Collaboration Shift [Yahoo! Finance]

Protagonist Therapeutics, Inc.  (PTGX) 
Last protagonist therapeutics, inc. earnings: 3/10 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.protagonist-inc.com
PDF US$44.38 million for the quarter and US$130.15 million for the year, alongside weaker per-share performance. At the same time, the company advanced its pipeline by sub [Read more]